Osaka, Japan

Mitsuhiro Iwasaki


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsuhiro Iwasaki: Innovator in Pharmaceutical Chemistry

Introduction

Mitsuhiro Iwasaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods of producing key chemical compounds. With a total of three patents to his name, Iwasaki's work has implications for the development of pharmaceutical agents.

Latest Patents

One of Iwasaki's latest patents is a production method of racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid C1-6 alkyl ester. This invention relates to an efficient method for producing (R)-3-hydroxy-3-(2-phenylethyl)hexanoic acid through the optical resolution of racemic mixtures. The method utilizes an optically active amine, resulting in a product that is useful as a starting material for pharmaceutical agents, characterized by high optical purity and yield. Another significant patent involves a synthetic intermediate for epothilone derivatives, showcasing his expertise in creating valuable chemical intermediates.

Career Highlights

Throughout his career, Mitsuhiro Iwasaki has worked with prominent companies in the chemical industry, including Sumika Fine Chemicals Co., Ltd. and Sumitomo Chemical Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Iwasaki has collaborated with notable colleagues such as Nobushige Itaya and Masahide Tanaka. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in his field.

Conclusion

Mitsuhiro Iwasaki stands out as an influential inventor in pharmaceutical chemistry, with a focus on innovative production methods for important chemical compounds. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…